162 results on '"Masoudi, Frederick A."'
Search Results
2. 2024 ACC Expert Consensus Decision Pathway for Treatment of Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee
3. Development and validation of an automated algorithm for end point adjudication for a large U.S. national registry
4. Antithrombotic Therapy After Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation
5. The National Cardiovascular Data Registry Data Quality Program 2020: JACC State-of-the-Art Review
6. The bleeding risk treatment paradox at the physician and hospital level: Implications for reducing bleeding in patients undergoing percutaneous coronary intervention
7. Dissemination of Transcatheter Aortic Valve Replacement in the United States
8. 2020 American Heart Association and American College of Cardiology Consensus Conference on Professionalism and Ethics: A Consensus Conference Report
9. CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection Fraction
10. 2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee
11. STS-ACC TVT Registry of Transcatheter Aortic Valve Replacement
12. International Consortium for Health Outcomes Measurement (ICHOM): Standardized Patient-Centered Outcomes Measurement Set for Heart Failure Patients
13. CCS/CHFS Heart Failure Guidelines: Clinical Trial Update on Functional Mitral Regurgitation, SGLT2 Inhibitors, ARNI in HFpEF, and Tafamidis in Amyloidosis
14. Improving Care Pathways for Acute Coronary Syndrome: Patients Undergoing Percutaneous Coronary Intervention
15. Machine Learning Prediction of Mortality and Hospitalization in Heart Failure With Preserved Ejection Fraction
16. Incremental Cost of Acute Kidney Injury after Percutaneous Coronary Intervention in the United States
17. Implications of Guideline Updates for the Management of Apparent Treatment Resistant Hypertension in the United States (A NCDR Research to Practice [R2P] Project)
18. Digoxin Use and Associated Adverse Events Among Older Adults
19. 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways
20. Prevalence, awareness, treatment, and control of hypertension in China: data from 1·7 million adults in a population-based screening study (China PEACE Million Persons Project)
21. Availability, cost, and prescription patterns of antihypertensive medications in primary health care in China: a nationwide cross-sectional survey
22. 2017 Comprehensive Update of the Canadian Cardiovascular Society Guidelines for the Management of Heart Failure
23. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
24. Implications of the LEGACY trial on US Atrial Fibrillation Patients: An NCDR Research to Practice (R2P) Project
25. Survival After Secondary Prevention Implantable Cardioverter-Defibrillator Placement: An Analysis From the NCDR ICD Registry
26. 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
27. Prevalence and Prognosis of Hyperkalemia in Patients with Acute Myocardial Infarction
28. Insurance and Prehospital Delay in Patients ≤55 Years With Acute Myocardial Infarction
29. Does Age Influence Cardiac Resynchronization Therapy Use and Outcome?
30. State Mandated Public Reporting and Outcomes of Percutaneous Coronary Intervention in the United States
31. ST-segment elevation myocardial infarction in China from 2001 to 2011 (the China PEACE-Retrospective Acute Myocardial Infarction Study): a retrospective analysis of hospital data
32. The Impact of Extreme-Risk Cases on Hospitals’ Risk-Adjusted Percutaneous Coronary Intervention Mortality Ratings
33. ACC/AHA/AACVPR/AAFP/ANA Concepts for Clinician–Patient Shared Accountability in Performance Measures: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures
34. In-Hospital Complications Associated With Reoperations of Implantable Cardioverter Defibrillators
35. Prevalence of Guideline-Directed Medical Therapy Among Patients Receiving Cardiac Resynchronization Therapy Defibrillator Implantation in the National Cardiovascular Data Registry During the Years 2006 to 2008
36. ACC/AHA Statement on Cost/Value Methodology in Clinical Practice Guidelines and Performance Measures: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines
37. Prevalence, Correlates, and Temporal Trends in Antiarrhythmic Drug Use at Discharge After Implantable Cardioverter Defibrillator Placement (from the National Cardiovascular Data Registry [NCDR])
38. Contemporary Incidence, Predictors, and Outcomes of Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Interventions: Insights From the NCDR Cath-PCI Registry
39. Cardiovascular Care Facts: A Report From the National Cardiovascular Data Registry: 2011
40. Beyond Medication Prescription as Performance Measures: Optimal Secondary Prevention Medication Dosing After Acute Myocardial Infarction
41. 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
42. 2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
43. Use of Stress Testing and Diagnostic Catheterization After Coronary Stenting: Association of Site-Level Patterns With Patient Characteristics and Outcomes in 247,052 Medicare Beneficiaries
44. Effectiveness of Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy in Heart Failure
45. A-24 | Association of COVD-19 Pandemic with Percutaneous Coronary Interventions for ST Elevation Myocardial Infarction within a Large National Healthcare System
46. Downstream Testing and Subsequent Procedures After Coronary Computed Tomographic Angiography Following Coronary Stenting in Patients ≥65 Years of Age
47. Red Blood Cell Indices and Development of Hospital-Acquired Anemia During Acute Myocardial Infarction
48. FINANCIAL ANALYSIS OF SITE-LEVEL CLINICAL TRIAL PERFORMANCE
49. ACCF/AHA Methodology for the Development of Quality Measures for Cardiovascular Technology: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures
50. ACCF/AHA 2011 Health Policy Statement on Therapeutic Interchange and Substitution: A Report of the American College of Cardiology Foundation Clinical Quality Committee
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.